Patent Grant
10314766
The present disclosure generally relates to medicament packaging and more particularly to a dispensing device and system that provides a medication regimen and a method for treatment of a medical condition.
Retail customers and/or patients can be engaged in a medical therapy, which may include diet, exercise and/or a prescription and/or a non-prescription medication dosing regimen, which may be employed to treat an illness. In some cases, hospitalized patients are often discharged and instructed by one or more medical practitioners to comply with a medical therapy.
Such medication dosing regimen can include one or a plurality of medications administered over a regimen, which may include one or more medications. The medication dosing regimen can require administration of medications simultaneously, at different times and/or according to days of a week or time of day. Such medication regimens may be administered in addition to existing medication regimens that a user may take for nutritional, therapeutic and/or illness treatment.
Such medication regimens, however, often suffer from poor patient compliance. In fact, many patients fail to comply with their medication regimens. In some cases, life-style related medications may also suffer from poor user compliance. Factors that contribute to non-compliance may include complexity of medication regimen, patient failure in filling prescriptions, incorrect order and/or prescription, cost, adverse side effects, patient reluctance, lack of motivation, non-reconciliation with existing medication and/or patient physiological issues.
Various medications of a medication regimen can be dispensed from a medication container such as single dose and/or multiple dose blister packaging to a user with or without tamper resistance. Multiple dose blister packaging can dispense a single medication according to a regimen including day, e.g., Monday, Tuesday, etc. and/or time of day. This disclosure describes an improvement over these technologies.
In one embodiment, a medicament dispensing container is provided. The medicament dispensing container includes a first wall connected with a second wall and defines a cavity therebetween. The walls are movable between an open configuration and a closed configuration. At least one member is disposable in the cavity and defines at least one dose receptacle configured for disposal of at least one dose of at least one medication. At least one fixation member connects the at least one member to at least one of the walls such that the at least one member is movable relative to the wall. Systems and methods of use are disclosed.
The present disclosure will become more readily apparent from the specific description accompanied by the following drawings, in which:
The exemplary embodiments of a medicament packaging system and related methods of use disclosed are discussed in terms of dispensing devices for the treatment of various diseases, illness and/or ailments and more particularly, in terms of a medicament dispensing device and system that provides a medication regimen and/or, child or tamper resistance and a method for treatment of a medical condition. In some embodiments, the present system is employed with a method for distribution of medication packaging to a patient for treatment of one or more diseases, illness and/or ailments. In some embodiments, the present system is employed with a method such that a patient is discharged from a health care facility, for example, short term discharge and/or long term discharge.
In one embodiment, the present system is employed with a method such that a patient is discharged from a health care facility, such as, for example, a hospital after one or more diseases, illness and/or ailments, such as, for example, myocardial infarction and may be prescribed one or more medications. In some embodiments, a patient may be directed and/or prescribed medication, such as, for example, an anti-platelet agent, aspirin, a beta-blocker, an ACE inhibitor, an ARB statin, nitro-glycerin, a docusate and/or anti-depressants. In some embodiments, the present system is employed to avoid failure of a patient to comply with such regimens and/or to take medications as prescribed or directed. In some embodiments, compliance failure can include the patient failing to refill the prescription, forgetting to take the prescribed medication, incomplete dosage and/or taking the medication at the incorrect time. In some embodiments, the present system is employed with a method for chronic dosing, for example, 30 day scripts or 90-100 day mail order refills. In some embodiments, the present system is employed with a method to facilitate compliance. In some embodiments, the present system is employed with a method to display and/or prove compliance. For example, a patient attending a practitioner appointment provides a present system, such as, for example, a compliance pack and displaying and/or showing the practitioner use of the compliance pack, which may include rupture of one or more blister packs to evidence compliance, as described herein. In some embodiments, the present system is employed with a method for distribution of medication packaging to a patient for treatment of one or more diseases, illness and/or ailments, such as, for example, pneumonia, heart failure, pain, infectious diseases that may include administration of medications, such as, for example, anti-retrovirals (ARV) for treatment of HIV/AIDS, dyslipidemia (high cholesterol), hypertension (high blood pressure), metabolic syndrome/insulin intolerance related to diabetes, psychological diseases and/or administration of transplant/anti-rejection drugs.
In some embodiments, the present system comprises a medicament dispensing system and methods of use for storage, transportation and discharge of medications for the treatment of a medical condition. In some embodiments, the present system comprises a medicament dispensing system and methods of use for storage, transportation and discharge of medications including those for treating illnesses, such as, for example, elevated blood pressure, dyslipidemia (high cholesterol), diabetes, metabolic syndrome, heart failure, pneumonia, cardiac deficiencies, arthritis, illnesses in which pain is part of an on-going treatment plan, and/or life-style related medications such as, for example, birth control pills, hormone replacement pills and nutritional supplements, such as, for example, neutraceuticals, for example, having vitamin A, D, and E with a calcium supplement. In some embodiments, the method includes treatment of a heart condition following a myocardial infarction. In one embodiment, the systems and methods of the present disclosure are employed to aid a person with a medical condition requiring administration of multiple pills, doses or schedules as part of a regimen. In one embodiment, the systems and methods of the present disclosure include a medicament dispensing device that provides child and/or tamper resistance, while being easily accessed by an adult.
In one embodiment, the medication container may include multiple medications on a blister card. In one embodiment, the medication container is disposable after a certain period of time, such as, for example, about one week to about 90 days, with a specific embodiment being disposable after two weeks for up to 5 medications to be taken once a day. In some embodiments, one or more blister cards are provided pre-filled with medication, as described herein, from a manufacturer. In some embodiments, a practitioner, such as, for example, a pharmacist determines and selects one or more of the pre-filled blister cards based on doctor's prescription and creates the medication container. In some embodiments, the manufacturer provides a medication container packed with selected blister cards and pre-filled medication according to the doctor's prescription. In one embodiment, the medication container includes a self-sealing punch card filled by a pharmacist. In one embodiment, the medication container includes a seven day regimen blister strip. In one embodiment, the medication container is approximately nine inches in length and width.
In some embodiments, the medication container includes one or a plurality of blister cards that hold multiple medications, for example, the medication container can include a range of one through ten blister cards that hold multiple medications. In some embodiments, the medication container includes two unit dose blister cards that hold multiple medications. In some embodiments, a pharmacist applies prescription labels and supplied product image labels to inside covers of the medication container. In some embodiments, a pharmacist inserts unit dose blister cards, dosing schedule labels and inserts into the medication container. In some embodiments, the blister cards include receptacles for seven days of medication. In some embodiments, the blister cards may include up to five different medications. In some embodiments, a pharmacist uses a supplied blister filling unit to facilitate in blister card assembly. In some embodiments, the blister card includes a first surface having receptacles and a second surface including tearing areas to be joined together by a pharmacist. In some embodiments, a pharmacist peels a protective backing from an adhesive strip on the first surface, aligns the sides of the first surface and the second surface, and applies the second surface to the first surface. In some embodiments, the first and second surfaces are folded at a crease and pressed together to permanently adhere the first and second surfaces and create the blister card. In some embodiments, the blister card includes apertures for applying individual blister strip inserts to customize a blister card for a patient. In some embodiments, a pharmacist applies the blister strip inserts into the apertures to assemble the blister card. In some embodiments, the second surface is foldable relative the first surface and the pharmacist folds the second surface onto the first surface to close the blister card. In some embodiments, a pharmacist or medical practitioner inserts the assembled blister cards into the medication container.
In some embodiments, the medication container includes product image stickers applied to the inside covers of the medication container. In some embodiments, the medication container includes prescription labels that are applied to the product image labels. In some embodiments, the medication container includes a seven day dosing schedule that corresponds with the day the regimen starts. In some embodiments, the medication container includes a week label to be applied to the outside covers of the medication container.
In one embodiment, the medication container includes two small organizers, such as, for example, a week one organizer and a week two organizer. In some embodiments, labels are applied to the top cover of the organizers to identify the order in which medication is to be taken by a patient. In one embodiment, the organizers include a child and/or tamper resistant lock, such as, for example, two white plastic pieces on the outside of the organizer configured in a push and slide configuration.
In some embodiments, the medication container comprises up to six blister cards. In some embodiments, the medication container comprises fasteners to lock the blister cards into place. In some embodiments, each blister card folds up to allow a patient to easily dispense tablets.
In some embodiments, one or more medication containers may be stacked to facilitate transportation and storage. In some embodiments, the medical container has dimensions of about 8″H×8.5″W×0.9″D. In some embodiments, the medical container has dimensions of about 9.5″H×10.5″W×0.9″D. In some embodiments, the medical container has dimensions of about 9″H×9.5″W×0.9″D. In some embodiments, the medication container includes a first blister card attached to a top surface of the container and a second blister card attached to a bottom surface of the container. In some embodiments, the first blister card includes one or a plurality of rows of large receptacles and/or the second blister card includes one or a plurality of rows of small receptacles. In some embodiments, the first blister card includes two rows of large receptacles and the second blister card includes three rows of small receptacles. In some embodiments, pharmacy labels are positioned on inside surfaces of top and bottom covers of the medical container. In some embodiments, pharmacy labels are positioned on the front of the individual blister cards. In some embodiments, dosing schedule labels are applied to the blister cards. In some embodiments, dosing schedule pages are retained in front of the blister cards.
In some embodiments, the blister cards are permanently fixed in place relative to the medication container once installed to provide tamper resistance and/or child resistance features to the medication container. In some embodiments, the blister cards are removable from the medication container and are replaceable with other blister cards. In some embodiments, the blister cards are removable through use of a tool configured for removal of the blister cards from the medication container. In some embodiments, the blister cards are removable and/or replaceable through use of the tool. In some embodiments, the blister cards are removable and/or replaceable through use of the tool as part of a refillable system, which may include the cover or outer shell being re-useable. In some embodiments, a pharmacist or medical practitioner may remove or reposition blister cards as needed and permanently lock the cards by breaking off a tab from a clip holding the card in place to resist and/or prevent the patient from easily removing cards.
In some embodiments, the medical container comprises a flip book, as described herein, and has no added parts or added assembly. In some embodiments, the flip book automatically re-locks when the flip book is closed. In some embodiments, the flip book is opened by squeezing tabs from below with one hand while pulling up on a handle with the other hand. In some embodiments, the flip book includes tabs that are 5″ apart, which comprise tamper resistance and/or child resistance features such that the tabs are too far apart for a child to squeeze with one hand. In some embodiments, the flip book includes a simplified tabbed opening design, which includes rounded shapes. In some embodiments, the flip book is paired with a case that holds discharge documents and accessories.
In some embodiments, the medical container comprises closures and opening tabs, and/or a tamper resistance and/or a child resistance push/slide lock. In some embodiments, the medical container comprises internal card retaining clips. In some embodiments, the clips include a hook, which does not allow cards to be removed. In some embodiments, the clips include a hook, which allow removable/replaceable cards. In some embodiments, the clips allow pharmacists to remove or reposition medicine cards as needed and permanently lock the cards by breaking off a tab from the clip to resist and/or prevent the patient from easily removing cards.
In one embodiment, the medication container includes a simple child resistant non-collapsible box filled with punch cards. In one embodiment, the medication container includes pharmacist insert strips of blisters and seal cards. In one embodiment, the medication container organizes medicines by week and/or by day and/or by time of day. In one embodiment, the medication container includes a simpler user interface. In one embodiment, the medication container includes a system to easily track medicine dosage compliance. In one embodiment, the medication container is manufactured with minimal material to reduce cost. In one embodiment, the medication container is configured to include various educational materials and/or blister cards.
In one embodiment, the medicament dispensing system provides a complex dosage regimen for medications for a period of time, such as, for example, two weeks. In some embodiments, the complex dosage regimen for the medications is provided for a period lasting until a patient's first outpatient visit following release from a hospital. In one embodiment, one or more medications are included in a medicament dispensing system. In one embodiment, medications prescribed to a patient following a medical procedure are included in a medicament dispensing system. In one embodiment, medications previously being taken by a patient are included in a medicament dispensing system.
In some embodiments, the present system comprises medication packaging that includes one or more medications. In some embodiments, the medication packaging includes a member, such as, for example, a unit dose page including indicia. In some embodiments, the indicia include information regarding medication and dosages required by a prescribed and/or non-prescribed regimen. In some embodiments, the indicia include a description of medication, which may include a name of a drug and a medical effect of a drug. In one embodiment, the unit dose page may include indicia that represent other medications or dosages to accommodate patients as needed. In one embodiment, the unit dose page may include space for adding indicia that represent other medications or dosages to accommodate patients as needed. In one embodiment, the indicia are screen printed on the unit dose page. In one embodiment, the indicia are hand written on the unit dose page.
In some embodiments, the medicament dispensing system is partially or entirely filled and packaged by a pharmacist. In some embodiments, the medicament dispensing system comprises a resilient material, such as, for example, cardboard. In some embodiments, the medicament dispensing system provides a child-resistant package while being easily accessible by an adult. In some embodiments, a method for accessing medication within the medicament dispensing system is provided. In some embodiments, the method includes the step of requiring consecutive and/or simultaneous motions difficult for children to perform but simple for an adult to perform. In one embodiment, the medication packaging comprises a slidable locking mechanism. In some embodiments, the locking mechanism is movable between a non-locked position and a locked position. In some embodiments, the locking mechanism provides audible indication of movement between a non-locked position and a locked position.
In one embodiment, the medication container comprises an outer sleeve and an inner container, such as, for example, a scroll pack. In some embodiments, the medication container is configured to organize multiple medicines in an easily understood manner. In some embodiments, the sleeve and/or the inner container are made from card stock. In some embodiments, the inner container is configured to be removed from the sleeve to allow a patient access to medicaments held therein. In some embodiments, the inner container is tethered to the sleeve. In some embodiments, the sleeve comprises an open face from which the inner container is removed. In some embodiments, the sleeve includes a tab to engage and lock the inner container in place. In some embodiments, the inner container comprises a plurality of medication cards and is configured to be unwound after being removed from the sleeve. In some embodiments, each of the medication cards is configured to fold over itself and forms a generally rectangular cross sectional shape. In some embodiments, the medication cards are folded along a longitudinal axis, such that a front-facing outer surface comprises a medication strip, and a front-facing inner surface comprises a medication information label. In some embodiments, the inner container is sized to fit a number of medication cards for a patient's treatment regimen. In some embodiments, the inner container is configured to hold five medication cards. In some embodiments, the inner container can be sized to fit at least one card.
In some embodiments, the inner container is a segmented strip having pre-made folding lines defining medication card portions arranged in an alternating pattern. In some embodiments, the medication card portions comprise folding flaps configured to fold over a medication card and hold it in place. In some embodiments, the medication card comprises cutouts corresponding to the folding flaps of the inner container. In some embodiments, inner surfaces of the folding flaps comprise an adhesive material to adhere to the medication card to the scroll. In some embodiments, when all medication cards are adhered to the scroll container, multiple medication dosages are presented in a grid to present a patient's dosage regimen in an easily read manner.
In some embodiments, each medication card comprises seven receptacles for medicament doses, one for each day of the week. In some embodiments, the medication cards are arranged with indicia illustrating the day of the week corresponding with the intended dosage. In some embodiments, the medication cards are arranged to facilitate compliance with a complex dosage regimen. In some embodiments, the medication cards are configured such that a patient may take one medication from each medication card each day. In some embodiments, the medication cards are configured such that a patient takes all ‘Monday’ dosages at once, which are organized along a vertical column of the grid. In some embodiments, the medication cards are configured such that after taking the dosages, the crushed remnants remaining in the receptacles indicate a compliance record and direct the patient to take the dosages for the next day.
In some embodiments, the medication container comprises an outer sleeve and an inner container having a plurality of medication cards arranged in a step-like manner. In some embodiments, the medication cards are arranged on a sloped structure such that each of the cards is partially visible to a patient. In some embodiments, the container comprises a plurality of medication cards. In some embodiments, each of the medication cards is configured to fold over itself to form a generally rectangular cross sectional shape. In some embodiments, the medication cards are folded along a longitudinal axis, such that a front-facing outer surface comprises a medication strip, and a front-facing inner surface comprises a medication information label. In some embodiments, the medication cards include a bottom member having a plurality of receptacles and a removable lid. In some embodiments, the medication cards comprise seven receptacles each, one for each day of the week. In some embodiments, the lid comprises a foil comprising seven strips, each of the strips configured to cover a corresponding receptacle. In some embodiments, the foil strips can be peeled from the bottom member to allow access to a medicament dosage held within the receptacle. In some embodiments, the strips comprise an end portion comprising indicia, such as color, a number, or a day of the week, to illustrate to a patient a day of the week corresponding with the intended dosage. In some embodiments, the strips are separable by perforated lines. In some embodiments, the receptacles are configured to be crushed or disfigured by a patient to release the medicament dosage held within. In some embodiments, the medication cards are overlaid on one another such that the indicia of each card is visible. In some embodiments, the medication cards are arranged such that a patient can easily discern which medicaments remain on a given day and which medicaments have been taken already. In some embodiments, the medication container has a length of about 8.25 inches, a width of about 4.754 inches, and a height of about 1.75 inches.
In some embodiments, the sleeve includes a surface having a locking mechanism. In some embodiments, the locking mechanism includes a press button and a gripping aperture. In some embodiments, the locking mechanism is actuated by a patient pressing the button to release the container from the sleeve. In some embodiments, the patient pulls from the gripping surface to separate the container from the sleeve.
In some embodiments, the medication container comprises closures and opening tabs, and/or a tamper resistance and/or a child resistance push/slide lock. In some embodiments, the medication container comprises internal card retaining clips. In some embodiments, the clips include a hook to prevent removal of the medication cards. In some embodiments, the clips include a hook that is configured to allow a patient to remove and/or replace medication cards. In some embodiments, the clips allow pharmacists to remove or reposition medicine cards as needed and permanently lock the cards by breaking off a tab from the clip to resist and/or prevent the patient from easily removing cards.
In some embodiments, the medication container includes a panel disposed on a top surface of the medication container. In some embodiments, the panel is configured to be opened and may include, such as, for example, additional product literature, a place for the patient to take notes about their experiences with the medicines, and/or helpful tips. In some embodiments, the panel can be utilized without opening the medication container.
In some embodiments, the medication container includes a closure panel having a flap configured for opening and closing the medication container. In some embodiments, the flap is configured to be tucked into the medication container. In some embodiments, the flap is configured to completely close the medication container during transit or when not in use.
In some embodiments, the medication container includes a flap having a half moon shaped opening configured to facilitate opening and closing. In some embodiments, the flap having a half moon shaped opening configured to facilitate opening with a dragging motion. In some embodiments, the medication container is manufactured from a single piece of card stock, which can include folded and/or glued components.
In one embodiment, the present system includes a medication treatment regimen comprising a plurality of medications. In one embodiment, the medicament dispensing system provides an organization of each medication in a patient's complex dosage regimen. In one embodiment, each distinct medication in the regimen is stored on separate unit dose pages contained in a medicament packaging container. In one embodiment, the present system is employed with a method that includes one or a plurality of days of therapy provided on each unit dose page. In one embodiment, the present system is employed with a method that includes fourteen days of therapy provided on each unit dose page. In one embodiment, medication packaging includes one or more unit dose pages assembled, filled and sealed by a pharmacist. In one embodiment, the medicament packaging container is child resistant and the unit dose pages are not child resistant.
The present disclosure may be understood more readily by reference to the following detailed description of the embodiments taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this application is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting. Also, in some embodiments, as used in the specification and including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It is also understood that all spatial references, such as, for example, horizontal, vertical, top, upper, lower, bottom, left and right, are for illustrative purposes only and can be varied within the scope of the disclosure. For example, the references “upper” and “lower” are relative and used only in the context to the other, and are not necessarily “superior” and “inferior”.
As used in the specification and including the appended claims, “treating” or “treatment” of a disease or condition may include administering one or more medications to a patient (human or other mammal). Alleviation can occur prior to signs or symptoms of the disease or condition appearing, as well as after their appearance. Thus, treating or treatment includes preventing or prevention of disease or undesirable condition (e.g., preventing the disease from occurring in a patient, who may be predisposed to the disease but has not yet been diagnosed as having it). In addition, treating or treatment does not require complete alleviation of signs or symptoms, does not require a cure, and specifically includes procedures that have only a marginal effect on the patient. Treatment can include inhibiting the disease, e.g., arresting its development, or relieving the disease, e.g., causing regression of the disease. For example, treatment includes, but is not limited to, reducing acute or chronic inflammation, inducing an anti-platelet effect, reducing hypertension, and lowering cholesterol.
In some embodiments, a biologically-active substance includes any substance or substances comprising a medicament, medication or drug including an active therapeutic substance, metabolite, hormone, steroid, vitamin, fatty acid, amino acid, sugar, carbohydrate, polypeptide or mineral. In some embodiments, a biologically-active substance includes any substance used for treatment, prevention, diagnosis, cure or mitigation of disease or illness. In some embodiments, a biologically-active substance includes any substance that affects anatomical structure or physiological function. In some embodiments, a biologically-active substance includes any substance that alters the impact of external influences on an animal, or metabolite thereof. In some embodiments, a complex dosage regimen includes a systematic administration of multiple dosage units at designated times during the day. In some embodiments, a dose includes each individual release of substance into body tissue.
The following discussion includes a description of a medicament dispensing system including a medicament dispensing container, related components and methods of employing the medicament dispensing system. Alternate embodiments are also disclosed. Reference is made in detail to the exemplary embodiments of the present disclosure, which are illustrated in the accompanying figures. Turning to
The components of medicament dispensing system 10, individually or collectively, can be fabricated from materials suitable for storage and dispensing of medication. In some embodiments, such materials include metals, ceramics, synthetic polymers such as thermoplastics, semi-rigid and rigid materials, elastomers, fabric and/or their composites. Various components of medicament dispensing system 10 may have material composites, including the above materials, to achieve various desired characteristics such as strength, rigidity, elasticity, compliance, and durability. The components of medicament dispensing system 10, individually or collectively, may also be fabricated from a heterogeneous material such as a combination of two or more of the above-described materials. The components of medicament dispensing system 10 may be monolithically formed, integrally connected or include fastening elements and/or instruments, as described herein.
Medicament dispensing system 10 includes a medicament dispensing device, such as, for example, a medicament dispensing container 12. Medicament dispensing container 12 includes a wall, such as, for example, a cover 14 and a wall, such as, for example, cover 24. Cover 14 includes a bottom section 16, a front sidewall 18, and opposing sidewalls 20. Walls 18, 20 define a surface 22. In one embodiment, bottom section 16 comprises a rectangular shape. Sidewalls 20 are disposed on opposing sides of bottom section 16 such that sidewall 18 extends between sidewalls 20.
Cover 24 includes a top section 26, a front sidewall 28, and opposing sidewalls 30. Sidewalls 30 are disposed on opposing sides of top section 26 such that sidewall 28 extends between sidewalls 30. Walls 28, 30 define a surface 32. In one embodiment, top section 26 comprises a rectangular shape. Surface 22 is configured to mate with surface 32 to close medicament dispensing container 12. In some embodiments, surface 22 mates with surface 32 via clips, clasps, magnet, key/keyway, interference fit, friction fit, hinged part, male/female part and/or adhesive.
In some embodiments, medicament dispensing container 12 includes a connecting portion, such as, for example, a spine 40. Spine 40 extends between cover 14 and cover 24 such that cover 24 is pivotable relative to cover 14. Cover 24 is attached to spine 40 at an end opposite sidewall 28, and cover 14 is attached to spine 40 at an end opposite sidewall 18. Cover 24 is pivotable relative to cover 14 between an open or non-locked configuration, as shown in
In some embodiments, cover 24 is rotatable relative to cover 14 through an angular range of 0 through 360 degrees. In a closed configuration, as shown in
In some embodiments, in a closed configuration, similar to that described herein, cover 24 and cover 14 provide a child resistant medicament dispensing container. In an open configuration, similar to that described herein, cover 14 is rotated relative to cover 24 such that medicament dispensing container 12 rests flatly on a surface to facilitate ease of access to the contents of the cavity of container 12. In one embodiment, medicament dispensing container 12 is sized to facilitate carrying and storage of printer paper, such as, for example, 9 inches by 12 inches. In some embodiments, medicament dispensing container 12 is sized to facilitate carrying and storage of one or more unit dose packs, such as, for example, 9.5 inches by 9.5 inches by 0.9 inches.
Medicament dispensing container 12 includes a mechanism configured to connect cover 14 with cover 24 for disposal of the components of medicament dispensing container 12 in a closed configuration. In some embodiments, cover 14 and/or cover 24 is provided with indicia, such as, for example, instructions to aid a user patient in use of medicament dispensing container 12. The instructions may be presented in the form of a graphic, such as, for example, a bull's eye, or text, such as, for example, “push here”.
Medicament dispensing container 12 includes locking mechanism 50 comprising a slide 54, such as, for example, two slides 54, disposed on opposite sides of covers 14, 24 at a corner defined by front walls 18, 28 and sidewalls 20, 30. Each slide 54 includes a male engagement portion, such as for example, a flange 56 configured to engage cover 24. Cover 24 includes an outer surface 42 that defines slots corresponding to each slide 54. The slots extend a distance from sidewalls 20, 30 toward each other along front walls 18, 28. The slots are configured to facilitate translation of flanges 56 such that slides 54 are translated, in the direction shown by arrow A in
In some embodiments, locking mechanism 50 audibly clicks to indicate a locked configuration, similar to that described herein. In some embodiments, locking mechanism 50 is provided with instructions to aid a patient in use of container 12. In some embodiments, the instructions may be presented in the form of a graphic, such as, for example, an arrow with a lock, or text, such as, for example, “slide to unlock”. In some embodiments, the instructions may be printed on locking mechanism 50. Alternatively, in some embodiments, the instructions may be printed onto sidewall 18 adjacent locking mechanism 50.
Medicament dispensing container 12 comprises one or more unit dose pages 60 that store and/or contain one or more medications, such as, for example, a dose of at least one medication. The dose of medication(s) is enclosed and sealed in a plurality of receptacles 62. In some embodiments, medicament dispensing container 12 includes a plurality of pages 60. In one embodiment, each page 60 slides into slot 44 of clip 42 and includes a ridge 68 configured to correspond with a projection in slot 44, as shown in
In some embodiments, medicament dispensing container 12 comprises a disposable dispensing device that provides therapeutic and/or nutritional support to a patient by increasing compliance with a dosing regimen, as described herein. In some embodiments, medicament dispensing container 12 and/or one or more pages 60 include blister packs, which comprise a plurality of receptacles 62. In some embodiments, each receptacle 62 accommodates a dosage unit and isolates that dosage unit from other dosage units. In some embodiments, a biologically-active substance within each dosage unit will not come into contact with the biologically-active substance of other dosage units.
In some embodiments, medicament dispensing container 12 and/or one or more pages 60 include a blister pack comprising at least one row of a plurality of receptacles 62 and/or areas including indicia 64. In some embodiments, each area defines at least one receptacle 62. In some embodiments, each receptacle 62 is designed to hold only one dosage unit having either only one biologically-active substance or multiple storage-compatible substances. In some embodiments, each receptacle 62 is designed to hold a plurality of dosage units.
In some embodiments, each predetermined area including one or more receptacles 62 may have an independently removable or breakable seal. In some embodiments, each receptacle 62 is moisture resistant and independently sealed. In some embodiments, one or more receptacles 62 may comprise a blister pack including a push-through pack, which has a lid material of aluminum foil or aluminum foil laminate. In some embodiments, a base of one or more receptacles 62 may be plastic, such as, for example, PVC, polyamides, polyolefins, polyesters and laminates or multi-layered materials. In some embodiments, the lid foil of a receptacle 62 may be provided with a line of weakness in a region of each receptacle 62 such that the line of weakness may be a tab for gripping that enables a receptacle 62 to be exposed by manipulation of the lid foil.
In some embodiments, receptacle 62 may be made embossed, cast deep drawn or vacuum formed out of plastic, plastic laminates, plastic/paper laminates or plastic/metal foil laminates. In some embodiments, receptacle 62 comprises a barrier layer against gases and vapors, which may be fabricated from a metal foil such as an aluminum foil embedded in a plastic laminate or ceramic layers or metallic layers embedded between two plastic layers.
In some embodiments, a dose of medicament, medication or drug can include, such as, for example, a chewable tablet, quick dissolve tablet, effervescent tablet, reconstitutable powder, elixir, liquid, solution, suspension, emulsion, tablet, multi-layer tablet, bi-layer tablet, capsule, soft gelatin capsule, hard gelatin capsule, caplet, lozenge, chewable lozenge, bead, powder, granules, dispersible granules, cachets, douche, suppository, cream, topical, inhalant, aerosol inhalant, patch, particle inhalant, implant, depot implant, dragee, ampoule, ingestible, injectable, infusion, health bar, liquid, food, nutritive food, functional food, yogurt, gelatin, cereal, cereal coating, animal feed and/or combinations thereof.
In some embodiments, indicia 64 of a medication regimen, direction, instruction and/or prescription for administration of the medication regimen may include dosage day indicia, a specific day of the week, such as Monday, Tuesday, Wednesday, Thursday, Friday, Saturday, Sunday or an abbreviation of said day, a specific date or a general succession of days, such as day 1, day 2, day 3. In some embodiments, indicia 64 may include time indicia that may be, such as, for example, a general time of the day corresponding to each of receptacles 62 or a specific time of the day corresponding to each of receptacles 62, such as, for example, AM, PM, morning, afternoon, evening, day, night, daytime, nighttime and combinations thereof. In some embodiments, indicia 64 may include each separate row or column of a page 60 indicating a time of day, such as AM doses and PM doses. In some embodiments, receptacle 62 and/or an adjacent area may be color coded for time indicia. In some embodiments, one or more components of medicament dispensing system 10 may include a key defining or explaining color coding.
In some embodiments, a dose unit may comprise vitamin A, B vitamins, vitamin C, vitamin D, vitamin E, vitamin K, essential fatty acids, folic acid, iron, calcium, magnesium, potassium, copper, chromium, zinc, molybdenum, iodine, boron, selenium, manganese, derivatives thereof and/or combinations thereof. In some embodiments, biologically-active substances may include thiamin, thiamin pyrophosphate, riboflavin, flavin mononucleotide, flavin adenine dinucleotide, niacin, nicotinic acid, nicotinamide, niacinamide, nicotinamide adenine dinucleotide, tryptophan, biotin, pantothenic acid, ascorbic acid, retinol, retinal, retinoic acid, beta-carotene, 1,25-dihydroxycholecalciferol, 7-dehyrdocholesterol, alpha-tocopherol, tocopherol, tocotrienol, menadione, menaquinone, phylloquinone, naphthoquinone, calcium, calcium carbonate, calcium sulfate, calcium oxide, calcium hydroxide, calcium apatite, calcium citrate-malate, calcium gluconate, calcium lactate, calcium phosphate, calcium levulinate, phosphorus, potassium, sulfur, sodium, docusate sodium, chloride, magnesium, magnesium stearate, magnesium carbonate, magnesium oxide, magnesium hydroxide, magnesium sulfate, copper, iodine, zinc, chromium, molybdenum, carbonyl iron, ferrous fumarate, polysaccharide iron, and/or combinations and derivatives thereof.
In some embodiments, a dose unit may be prescription and/or non-prescription substances. In some embodiments, the prescription substance may be a hormone replacement agent, a contraceptive agent, an osteoporotic agent, a chemotherapeutic agent, an anti-infective agent, analgesic, a steroid, an appetite suppressant, a weight loss agent, a tobacco antagonist, a cholesterol reducer and/or combinations thereof.
In some embodiments, the prescription substances may include, such as, for example, ticagrelor (anti-platelet), clopidogrel (anti-platelet), prasugrel (anti-platelet), carvedilol (beta blocker), metoprolol succinate (beta blocker), metoprolol tartrate (beta blocker), lisinopril (ACE inhibitor), losartan (angiotensin receptor blocker), valsartan (angiotensin receptor blocker), atorvastatin (statin), simvastatin (statin), spironolactone (aldosterone receptor blocker/diuretic), atenolol, erythromycin, penicillins, cephalosporins, theophylline, albuterol, terbutaline, diltiazem, propranolol, nifedepine, clonidine, thioridazine, diazepam, meclizine, ergoloid mesylates, chlorpromazine, carbidopa, levodopa, beclomethasone diproprionate, budesonide, dexamehasone, flunisolide, fluticasone proprionate, mometasone furoate, triamcinolone acetonide, beconase, pulmicort, rhinocort, decadron, aerobid/nasolide, flovent/flonase, azmacort, amprenavir, adefovir dipivoxil, zidovudine, azidothymidine, AZT, paclitaxel, cyclophosphamide, teniposide, taxol, cytoxan, vumon, methotrexate, methotrexate, cisplatin, carboplatin, oxaliplatin, platinol, paraplatin, adriamycin, bleomycin, dactinomycin, daunorubicin, doxorubicin, indarubicin, mitomycin, blenoxane, cosmegen, cerubidine, rubex, indamycin, mutamycin, BCNU, streptozocin, vinblastine, thiotepa, conjugated estrogens, esterified estrogens, estropipate, estradiol, ethinyl estradiol, medroxyprogesterone, meprobamate, desogestrel, levonorgestrel, norethindrone, norethindrone acetate, norgestimate, norgestrel, raloxifene, tamoxifen, methyltestosterone, quinapril, sotalol, alendronate, atorvastatin, colestipol, clofibrate, and/or combinations thereof.
In some embodiments, the non-prescription substance can be a vitamin or derivative thereof, and/or a mineral compound or derivative thereof. In some embodiments, the vitamin or mineral compound may be, such as, for example, thiamin, thiamin pyrophosphate, riboflavin, flavin mononucleoride, flavin adenine dinucleotide, niacin, nicotinic acid, nicotinamide, niacinamide, nicotinamide adenine dinucleotide, tryptophan, biotin, folic acid, pantothenic acid, ascorbic acid, retinol, retinal, retinoic acid, beta-carotene, 1,25-dihydroxycholecalciferol, 7-dehydrocholesterol, alpha-tocopherol, tocopherol, tocotrienol, menadione, menaquinone, phylloquinone, naphthoquinone, calcium, calcium carbonate, calcium sulfate, calcium oxide, calcium hydroxide, calcium apatite, calcium citrate-malate, calcium gluconate, calcium lactate, calcium phosphate, calcium levulinate, phosphorus, potassium, sulfur, sodium, docusate sodium, chloride, magnesium, magnesium stearate, magnesium carbonate, magnesium oxide, magnesium hydroxide, magnesium sulfate, copper, iodine, zinc, chromium, molybdenum, carbonyl iron, ferrous fumarate, polysaccharide iron, and combinations and derivatives thereof. In some embodiments, the derivatives of vitamin compounds include salts, alkaline salts, esters and chelates of any vitamin compound. In some embodiments, the nonprescription substance can be a herbal compound, herbal extract, derivative thereof and/or combinations thereof.
In some embodiments, a medication regimen can include a first dosage unit arrayed on a blister pack of receptacles 62 adjacent to a second dosage unit. In some embodiments, the medication regimen includes a first dosage unit disposed adjacent to a second dosage unit disposed with different receptacles 62.
In some embodiments, as shown in
In one embodiment, page 60 comprises twenty-eight receptacles 62. One dosage unit is enclosed in each receptacle 62. Receptacles 62 are vertically arranged in two groupings of two rows adjacent to one another. The groupings are organized into weeks such that each grouping comprises fourteen receptacles 62. Page 60 comprises indicia 64 indicating the time and order in which the medications are to be taken by the patient. Each receptacle 62 is labeled with a number to indicate the day of a dosage regimen the medications should be taken. Indicia 64 include graphics to indicate the time of day the medications should be taken. Indicia 64 are screen printed on page 60. In some embodiments, indicia 64 may be hand written. Sections of page 60 are left blank to allow hand written notes or instructions by a patient, pharmacist or doctor.
In one embodiment, as shown in
In some embodiments, as shown in
In some embodiments, as shown in
In one embodiment, unit dose page 60 is configured to be inserted into a loading unit 80 configured to hold page 60 in place while a pharmacist or a medical practitioner fills receptacles 62 with medicaments, as shown in
Walls 82, 84 comprise a channel 88 along an inner surface to receive a page 60. Channel 88 runs along the entire length of the inner surfaces of walls 82, 84 and is wide enough to accommodate the thickness of a page 60. As shown in
In one embodiment, as shown in
Surfaces 61a and 61b are movable between a drug loading configuration, as shown in
In some embodiments, as shown in
In some embodiments, as shown in
In one embodiment, medicament dispensing system 10, similar to the systems and methods as described herein, including medicament dispensing container 12, as described herein, is employed in connection with treatment of a disease, illness and/or ailment of a patient. The components of medicament dispensing system 10 facilitate user/patient compliance with a medication regimen, as described herein, upon discharge from a health care facility, such as, for example, a hospital. In one embodiment, a patient utilizes medicament dispensing system 10 after being discharged from a hospital following a myocardial infarction and may be prescribed and/or directed to administer one or a plurality of prescription and/or non-prescription medications. For example, a patient may be prescribed an antiplatelet agent, aspirin, warfarin (anti-coagulant), a beta-blocker, an ACE inhibitor, a statin, nitro-glycerin, a docusate, and/or antidepressants in connection with treatment for the myocardial infarction.
In some embodiments, a medical practitioner and/or pharmacist reviews and/or considers medications including one or more prescriptions in connection with treatment for the myocardial infarction, one or more non-prescribed medications directed for administration by the patient in connection with treatment for the myocardial infarction, one or more existing prescriptions and/or one or more non-prescription medications and supplements being taken by the patient. The medical practitioner and/or pharmacist determine a medication regimen based on these medications using medicament dispensing system 10 to facilitate user/patient compliance with the medication regimen.
In some embodiments, based on the determined medication regimen, health care personnel, such as, for example, pharmacy personnel prepare selected unit dose pages 60 and/or labels 70, as described herein, for disposal with a selected medicament dispensing container 12 specifically created for the myocardial infarction and the user/patient upon discharge from the hospital.
Medicament dispensing container 12 is portable such that the user/patient transports and/or carries medicament dispensing container 12 upon discharge. Locking mechanism 50 is moved from a closed configuration, similar to that described herein, to an open configuration, similar to that described herein. The contents of container 12, which may include unit dose pages 60 and/or inserts 70, as described herein, are accessible to the user/patient. The user/patient employs the components of medicament dispensing system 10, for example, following direction via indicia 64 for administering dosage units from receptacles 62 and/or following instruction from indicia 64 and/or inserts 70, to facilitate user/patient compliance with the medication regimen in connection with treatment for the myocardial infarction. In some embodiments, locking mechanism 50 can be moved to a locked position such that medicament dispensing container 12 is disposable in a locked configuration, similar to that described herein, for storage and subsequent use.
In one embodiment, as shown in
Cover 124 includes a top section 126, a front sidewall 128, and opposing sidewalls 130. Sidewalls 130 are disposed on opposing sides of top section 126 such that sidewall 128 extends between sidewalls 130. Walls 128, 130 define a surface 132. Surface 122 is configured to mate with surface 132 to close medicament dispensing container 112.
In some embodiments, medicament dispensing container 112 includes a connecting portion, such as, for example, a spine 140. Spine 140 extends between cover 114 and cover 124 such that cover 124 is pivotable relative to cover 114. In some embodiments, spine 140 comprises a hinge. Cover 124 is attached to spine 140 at an end opposite sidewall 128, and cover 114 is attached to spine 140 at an end opposite sidewall 118. Cover 124 is pivotable relative to cover 114 between an open or non-locked configuration, similar to that described herein, as shown in
In some embodiments, cover 124 is rotatable relative to cover 114 through an angular range of 0 through 360 degrees. In a closed configuration, as shown in
In some embodiments, in a closed configuration, cover 124 and cover 114 provide a child and/or tamper resistant medicament dispensing container. In an open configuration, cover 114 is rotated relative to cover 124 such that medicament dispensing container 112 rests flatly on a surface to facilitate ease of access to the contents of the cavity of container 112.
Medicament dispensing container 112 includes a mechanism configured to connect cover 114 with cover 124 for disposal of the components of medicament dispensing container 112 in a closed configuration. In some embodiments, cover 114 and/or cover 124 is provided with indicia, such as, for example, instructions to aid a user patient in use of medicament dispensing container 112. The instructions may be presented in the form of a graphic, such as, for example, a bull's eye, or text, such as, for example, “push here”.
Medicament dispensing container 112 includes locking mechanism 150 comprising a slide 154, such as, for example, two slides 154, disposed on opposite sides of covers 114, 124 at a corner defined by front walls 118, 128 and sidewalls 120, 130. Each slide 154 includes a male engagement portion, such as for example, a flange 156 configured to engage cover 124. Surface 132 includes slots 158 that extend a distance from sidewalls 130 towards each other along front walls 118, 128. Slots 158 are configured to facilitate translation of flanges 156 such that slides 154 are translated, similar to the direction shown by arrow A in
In some embodiments, locking mechanism 150 audibly clicks to indicate a locked position. In some embodiments, locking mechanism 150 is provided with instructions to aid a patient in use of container 112. In some embodiments, the instructions may be presented in the form of a graphic, such as, for example, an arrow with a lock, or text, such as, for example, “slide to unlock”. In some embodiments, the instructions may be printed on locking mechanism 150. Alternatively, in some embodiments, the instructions may be printed onto sidewall 118 adjacent locking mechanism 150.
Medicament dispensing container 112 comprises one or more unit dose pages 160, similar to page 60 as described herein, which store and/or contain one or more medications, such as, for example, a dose of at least one medication. The dose of medication(s) is enclosed and sealed in a plurality of receptacles 162, similar to receptacles 62 as described herein. In some embodiments, medicament dispensing container 112 includes a plurality of pages 160. In one embodiment, the plurality of pages 160 is disposed in a tri-fold configuration, as shown in
Page 160 includes three openings 168 that are sized to be received by fasteners 142. Hooks 144 are configured to be disposed within openings 168 and under page 160 to capture page 160. Hooks 144 include an arcuate portion configured to fit through an opening 168. In some embodiments, page 160 includes a folding line 166, which allows page 160 to be folded to access the medicaments held within receptacles 162 of the page 160 and/or additional pages 160 attached to container 112 and positioned adjacent to the page 160. A first page 160 is held by a bottom row of fasteners 142 on section 116 or 126, and a second page 160 is held by a row of fasteners 142 above the bottom row such that the second page 160 must be folded up to gain access to the first page 160. In some embodiments, a third page 160 is applied to a third row of fasteners 142 in a similar fashion. In some embodiments, as shown in
As shown in
In some embodiments, as shown in
In some embodiments, medicament dispensing containers 12, 112 are configured to be stackable, as shown in
In one embodiment, as shown in
In some embodiments, page 260 includes an upper surface 261a and a bottom surface 261b. Surface 261a is joined to surface 261b at a folding line 267. In some embodiments, line 267 may be variously configured. For example, line 267 may comprise a line of perforations or a breaking line. Surface 261b is configured to be rotatable relative to surface 261a along line 267 such that surfaces 261a, 261b abut one another. Page 260 includes an opening 268a on surface 261a and an opening 268b on surface 261b that are configured to align when surface 261a and 261b are rotated to abut one another. The hole formed by openings 268a, 268b is sized to be received by fasteners 242. In some embodiments, surface 261a includes a weather resistant material configured to maintain a closed environment for medicaments held therein. Surface 261a includes receptacles 262, which define depressions sized to hold one or more medicaments therein. Surface 261b includes a resilient material configured to abut surface 261a. In some embodiments, surface 261a includes a foil layer, a laminate layer, and a resilient layer. In some embodiments, the resilient layer comprises a thin layer of paper or cardboard. In some embodiments, as shown in
In some embodiments, page 260 includes a folding line 266a on surface 261a and a folding line 266b on surface 261b. Line 266a provides an axis of rotation to allow surface 261a to be rotated to access the medicaments held within receptacles 262 of the surface 261a, as shown in
In one embodiment, as shown in
Container 312 is movable between an open or non-locked configuration, similar to that described herein, and a closed or locked configuration, similar to that described herein. When in the open configuration, latches 354 are disengaged from slots 356 such that cover 324 is freely rotatable relative to cover 314. When in the closed configuration, latches are snapped into slots 356 such that cover 324 is locked relative to cover 314. Latches 354 protrude from and are resiliently biased relative to cover 324. As container 312 is moved between the open configuration and the closed configuration, engagement of latches 354 with slots 356 cause latches 354 to bow and/or flex to fit into slots 356. To move container 312 from the closed configuration to the open configuration, a user presses latches 354, in the direction shown by arrows C in
In some embodiments, locking mechanism 350 audibly clicks to indicate a locked position. In some embodiments, locking mechanism 350 is provided with instructions to aid a patient in use of container 312. In some embodiments, the instructions may be presented in the form of a graphic, such as, for example, an arrow with a lock, or text, such as, for example, “press to unlock”. In some embodiments, the instructions may be printed on locking mechanism 350.
In one embodiment, as shown in
In some embodiments, medicament dispensing container 412 includes a plurality of medicament dispensing containers 412, as shown in
In one embodiment, organizer 480 includes a folder flap 482 attached to organizer 480 at a connecting portion, such as, for example, a spine 484. Spine 484 is disposed such that flap 482 is pivotable relative to spine 484. Flap 482 is pivotable relative to organizer 480 between an open or non-locked configuration, such as, for example a medication accessible configuration, and a closed or locked configuration, similar to that described herein.
In one embodiment, as shown in
In one embodiment, as shown in
In one embodiment, as shown in
In one embodiment, as shown in
In one embodiment, as shown in
In one embodiment, as shown in
In one embodiment, as shown in
In one embodiment, as shown in
Slides 1254 are lockable in the closed configuration, as shown in
In one embodiment, as shown in
Scroll container 1332 is configured for disposal within inner cavity 1320, as described herein. Scroll container 1332 is attached with sleeve 1312 by a fixation member, such as, for example, a tether 1333. Tether 1333 is configured such that scroll container 1332 is drawn from sleeve 1312 but not detachable from sleeve 1312. In some embodiments, scroll container 1332 is attached to an inner surface of a sidewall 1318 positioned opposite the opening to inner cavity 1320. In some embodiments, scroll container 1332 is attached to an inner surface of top face 1314 or bottom face 1316 adjacent the opening to inner cavity 1320. Tether 1333 may be made from a material similar to that of sleeve 1312 and/or scroll container 1332, such as, for example, card stock that is adhered to an inner surface of sleeve 1312 with an adhesive material. In some embodiments, tether 1333 may comprise a material that is different from that of sleeve 1312 and scroll container 1332, such as, for example, a fabric or a polymer composite, such as nylon.
Tether 1333 is configured to provide a range of motion for movement of scroll container 1332 relative to sleeve 1312. In some embodiments, scroll container 1332 is pivotable about tether 1333 in an angular range of 0 to 360 degrees. In some embodiments, tether 1333 is configured to provide movement of scroll container 1332 within a predetermined distance from sleeve 1312 to allow scroll container 1332 to be unrolled.
In some embodiments, indicia is provided on sleeve 1312 to provide instructions to aid a user in removing scroll container 1332 from sleeve 1312. In some embodiments, the indicia are positioned on a surface of scroll container 1332 visible from an opening in sleeve 1312. For example, the indicia may be in the form of instructive text such as “pull here” that may be printed onto the surface of scroll container 1332. As shown in
In some embodiments, medicament dispensing system 10 is movable between a locked configuration, similar to that described herein, and a non-locked configuration, similar to that described herein. In some embodiments, sleeve 1312 includes a tab 1322 positioned at an edge of sleeve 1312 adjacent to inner cavity 1320. Tab 1322 is configured for disposal in a corresponding slot 1342 of scroll container 1332 accessible when scroll container 1332 is position within inner cavity 1320. Tab 1322 is rotatable relative to sleeve 1312 through an angular range of 0 through about 360 degrees. In some embodiments, tab 1322 is shaped to facilitate engagement with corresponding slot 1342. In some embodiments, tab 1322 is generally rectangular and may have a curved front edge to make engagement and disengagement with slot 1342 easier for a user. In some embodiments, tab 1322 may include alternate configurations, such as, for example, oval, oblong, triangular, rectangular, square, polygonal, irregular, uniform, non-uniform, variable, tubular and/or tapered. Tab 1322 is oriented on sleeve 1312 such that upon rotation of tab 1322 into the locked configuration, tab 1322 slides into corresponding slot 1342 to move from the non-locked configuration to the locked configuration. In some embodiments, instructive indicia are positioned adjacent tab 1322 to aid a user in moving medicament dispensing system 10 from the locked to the non-locked configuration. In some embodiments, the indicia are positioned on tab 1322. In some embodiments, the indicia are positioned on a surface of sleeve 1312 and/or scroll container 1332 adjacent tab 1322. In some embodiments, the indicia may be marked by an arrow indicating the direction of necessary movement to move tab 1322. In some embodiments, instructive text such as “lift here” may be printed on or adjacent to tab 1322 to indicate the direction of necessary movement to move tab 1322.
In some embodiments, scroll container 1332 comprises a plurality of medication card portions 1334 and spine portions 1336 in an alternating pattern. Medication card portions 1334 are sized to receive medication cards 1360, as discussed herein. When fully unrolled, scroll container 1332 extends from opening 1321 of sleeve 1312 to an end 1344 with spine portions 1336 being positioned between medication cards 1360. In various embodiments, medication card portions 1334 are wider than spine portions 1336. Portions 1334, 1336 are sized to allow rolling of scroll container 1332, as shown in
In some embodiments, medication cards 1360 are attachable to designated portions on scroll container 1332, such as medication card portions 1334. In some embodiments, medication cards 1360 are adhered to medication card portions 1334 with an adhesive material. In some embodiments, scroll container 1332 includes oppositely positioned flaps 1338 at each medication card portion 1334. Flaps 1338 are attached with scroll container 1332 at a fold line 1340, and extend beyond a width of medication card portions 1334 of scroll container 1332. Flaps 1338 are rotatable about folding lines 1340 relative to medication card portions 1334 through an angular range of 0 through about 360 degrees. Flaps 1338 are configured to receive an adhesive material such that when folded along folding lines 1340 and onto a medication card 1360, flaps 1338 will hold medication card 1360 in place, as discussed herein. Folding lines 1340 are indented from the edges of medication card portions 1334 to increase the reach of flaps 1338 over medication card 1360 placed over card portion 1334 for increased stability. In some embodiments, flaps 1338 extend from the edges of card portion 1334 such that folding lines 1340 are flush with the edges. In some embodiments, this configuration may be advantageous in manufacture involving certain materials. In some embodiments, as shown in
In some embodiments, medicament dispensing system 10 is movable between an open configuration, similar to that described herein, and a closed configuration, similar to that described herein, as shown in
When moving to the closed configuration, medication card portions 1334 and spine portions 1336 are rotated toward one another, in a direction shown by arrow H. The user rotates each medication card portion 1334 along folding lines positioned between medication card portions 1334 and spine portions 1336. A user rotates each consecutive medication card portion 1334 and spine portion 1336 in turn starting at terminal end 1344 until all medication cards 1360 are enclosed on the inside of scroll container 1332.
Scroll container 1332 comprises one or more medication cards 1360 that store and/or contain one or more medications, such as, for example, a dose of at least one medication. The dose of medication(s) is enclosed and sealed in a plurality of receptacles 1372. In some embodiments, scroll container 1332 includes a plurality of medication cards 1360. In some embodiments, medication cards 1360 include a central fold along a ridge 1362 to define a front portion 1364 and a rear portion 1366. In some embodiments, rear portion 1366 includes oppositely positioned cutouts 1368 sized and configured to receive flaps 1338 sized to fit within cutout 1368 of scroll container 1332, as shown in
In some embodiments, medication card 1360 comprises receptacles 1372 indicating a patient's daily dosage of medication held within medication card 1360. In some embodiments, medication card 1360 comprises indicia 1374, disposed with and displayed from a predetermined portion adjacent one or more receptacles 1372, indicating information regarding the medication enclosed within receptacles 1372. In some embodiments, receptacles 1372 are transparent or translucent and extend from a front-facing surface of portion 1364 to allow a user to easily view whether a medicament has been taken.
In some embodiments, medication card 1360 comprises seven receptacles 1372. One dosage unit is enclosed in each receptacle 1372. Receptacles 1372 are horizontally arranged in a row adjacent to one another. Medication card 1360 comprises indicia 1374 indicating the time and/or order in which the medications are to be taken by the patient. In some embodiments, each receptacle 1372 is labeled with an arrow having the day the dosage should be taken according to a dosage regimen. Indicia 1374 can be screen printed on medication card 1360. In some embodiments, indicia 1374 may be hand written. Sections of medication card 1360 may be left blank to allow hand written notes or instructions by a patient, pharmacist or doctor.
In some embodiments, scroll container 1332 includes several medication cards 1360 adhered to medication card portions 1334 and spaced apart by spine portions 1336. In some embodiments, each medication card 1360 includes one row of seven receptacles 1372. Each receptacle 1372 is positioned adjacent indicia 1374 to provide information relating to the medicaments held within the receptacles. Medication cards 1360 are aligned on the surface of scroll container 1332 such that each row of receptacles 1372 align into columns such that a first receptacle 1372 of each medication card 1360 is aligned into a first column, a second receptacle 1372 of each medication card 1360 is aligned into a second column, a third receptacle 1372 of each medication card 1360 is aligned into a third column, etc. The arrangement of receptacles 1372 aids a user in maintaining compliance with a complex dosage regimen. Thus, compliance with a complex dosage regimen, such as a regimen requiring multiple medications each day, is made easier by having visibility of each of the medications required to be taken at once in a column view. Similarly, a patient can easily tell which medicaments have been taken already, and which medicaments have yet to be taken by looking to the columns of receptacles 1372 which have been broken.
In some embodiments, medicament dispensing system 10 comprises one or more information labels 1380 to educate a patient about a medication being administered in the dosage regimen. In some embodiments, label 1380 comprises indicia, similar to that described herein, to indicate the name and/or nature of the medicine being administered. In some embodiments, the indicia include a list of possible side effects of the medications being administered. In some embodiments, the indicia provide instructions on how long a patient should take the medication being administered. In some embodiments, label 1380 is a sticker that is adhered onto a front-facing surface of portion 1366 and/or a rear-facing surface of portion 1364. Thus, label 1380 is positioned so that it may be viewed upon a user flipping open medication card 1360 to expose inner information surfaces.
In use, scroll container 1332 is portable such that the user/patient transports and/or carries scroll container 1332 upon discharge. Tab 1322 is moved from a locked configuration to a non-locked configuration, and scroll container 1332 is drawn from sleeve 1312, in the direction shown by arrow E in
Once a patient has accessed the medication required for the dosage regimen, scroll container 1332 is wound or rolled, in the direction shown by arrows H in
In one embodiment, as shown in
Container 1432 includes a plurality of medication cards 1460 disposed in a tiered configuration. Container 1432 includes opposing side walls 1434 which have a profile configured to slide into inner cavity 1426. In some embodiments, fasteners 1442 are configured to attach medication cards 1460 with container 1432, as described herein.
Container 1432 is configured for disposal within inner cavity 1426, as described herein. Container 1432 is attached with sleeve 1412 by a tether 1433. Tether 1433 is configured such that container 1432 is extendable from inner cavity 1426 but not detachable from sleeve 1412. Tether 1433 is configured to provide a range of motion for movement of container 1432 relative to sleeve 1412. In some embodiments, container 1432 is pivotable about tether 1433 in an angular range of 0 to 360 degrees. In some embodiments, tether 1433 is configured to provide movement of container 1432 within a predetermined distance from sleeve 1412 to allow container 1432 to be extended.
In some embodiments, instructive indicia are positioned adjacent an opening in sleeve 1412 to aid a user in removing container 1432 from sleeve 1412. In some embodiments, the indicia are positioned on a surface of container 1432 visible from an opening in sleeve 1412. For example, the indicia may be in the form of instructive text such as “pull here” that may be printed onto the surface of container 1432.
In some embodiments, medicament dispensing system 10 is movable between a locked configuration, similar to that described herein, and an non-locked configuration, similar to that described herein, as shown in
In the non-locked configuration, container 1432 is translated out of sleeve 1412, in a direction shown by arrow K in
Container 1432 includes tiered surfaces having fasteners 1442 configured to receive a medication card 1460. In some embodiments, each stepped surface includes two spaced apart fasteners 1442. In alternate embodiments, each step may include more or less fasteners 1442. For example, each step may include one or three fasteners 1442. A fastener 1442 projects from a stepped surface and is configured to hold a medication card 1460 in place. In some embodiments, fastener 1442 extends in a cantilever configuration from a stepped surface of container 1432. Each fastener 1442 includes a hook end configured for disposal with an opening 1468 for capture of a medication card 1460, as discussed herein. In some embodiments, container 1432 includes several rows of fasteners 1442 to hold multiple medication cards 1460 in place. In some embodiments, as shown in
Medication cards 1460 are configured to enclose doses of medication(s) in a plurality of receptacles 1472. In some embodiments, medication cards 1460 include a central fold along ridge 1462 to define a front portion 1464 and a rear portion 1466. Ridge 1462 is deflectable to define an axis of rotation for medication card 1460. In some embodiments, medication cards 1460 can be rotated to view and access information held on a rear-facing surface of portion 1466 or a front-facing surface of portion 1464. In some embodiments, medication card 1460 comprises one or more information labels 1480 to educate a patient about a medication being administered in the dosage regimen. In some embodiments, each medication card 1460 encloses a different medication such that each medication that is part of a patient's dosage regimen is organized on separate medication cards 1460. In some embodiments, medication card 1460 comprises receptacles 1472 indicating a patient's daily dosage of medication held within medication card 1460, as described herein.
Medication cards 1460 include openings 1468 that are sized to receive fasteners 1442 to fix medication cards 1460. In some embodiments, medication card 1460 includes a folding line 1470, which allows medication card 1460 to be folded to access the medicaments held within receptacles 1472 of medication card 1460 and/or additional medication cards 1460 attached to container 1432 and positioned adjacent to medication card 1460, as shown in
In some embodiments, medication card 1460 comprises indicia tabs 1474, disposed with and displayed from a predetermined portion adjacent one or more receptacles 1472, indicating information regarding the medication enclosed within receptacles 1472. In some embodiments, indicia tabs 1474 are presented as a color to convey information to a user. In some embodiments, tabs 1474 include a day of the week in which a user is to take the medication contained within a corresponding receptacle 1472. Tabs 1474 are removable from medication cards 1460. To facilitate gripping by a user, tabs 1474 extend beyond medication card 1460, as shown in
In some embodiments, container 1432 includes several medication cards 1460 arranged such that all tabs 1474 are arranged to be easily viewed by a user. In some embodiments, each medication card 1460 includes one row of seven tabs 1474. Each tab 1474 is positioned adjacent to a receptacle 1472 to provide information relating to the medicaments held within the receptacles. Medication cards 1460 are aligned in a tiered configuration on container 1432 such that each row of tabs 1474 aligns into columns, as shown in
In one embodiment, as shown in
Cover 1524 includes a top section 1526, a front sidewall 1528, and opposing sidewalls 1530. Sidewalls 1530 are disposed on opposing sides of top section 1526 such that sidewall 1528 extends between sidewalls 1530. In one embodiment, top section 1526 comprises a rectangular shape. In some embodiments, sidewall 1528 is configured to mate with sidewall 1518 to close medicament dispensing container 1512. In some embodiments, sidewall 1528 mates with sidewall 1518 via clips, clasps, magnet, key/keyway, interference fit, friction fit, hinged part, male/female part and/or adhesive.
Cover 1524 is attached with cover 1514 by a tether 1540. Tether 1540 is configured such that cover 1524 is extendable from cover 1514 but not detachable from cover 1522. Tether 1540 is configured to provide a range of motion for movement of cover 1524 relative to cover 1514. In some embodiments, cover 1524 is pivotable about tether 1540 in an angular range of 0 to 360 degrees. In some embodiments, tether 1540 is configured to provide movement of cover 1524 within a predetermined distance from cover 1514 to cover 1524 to extend and display medication cards 1560.
In a closed configuration, similar to that described herein, as shown in
In some embodiments, in a closed configuration, cover 1524 and cover 1514 provide a child and/or tamper resistant medicament dispensing container. In an open configuration, similar to that described herein, cover 1514 is rotated relative to cover 1524 such that medicament dispensing container 1512 rests flatly on a surface to facilitate ease of access to the contents of the cavity of medicament dispensing container 1512. In one embodiment, medicament dispensing container 1512 is sized to facilitate carrying and storage of printer paper, such as, for example, 9 inches by 12 inches. In some embodiments, medicament dispensing container 1512 is sized to facilitate carrying and storage of one or more unit dose packs, such as, for example, 9.5 inches by 9.5 inches by 0.9 inches.
Medicament dispensing container 1512 comprises one or more unit dose pages, such as, for example, medication cards 1560 that store and/or contain one or more medications, such as, for example, a dose of at least one medication. The dose of medication(s) is enclosed and sealed in a plurality of receptacles 1572. In some embodiments, medicament dispensing container 1512 includes a plurality of medication cards 1560. In one embodiment, each medication card 1560 is attached to a tether 1540 such that when the medication cards 1560 are in the extended state, receptacles 1572 of each medication card 1560 are visible to a user. In some embodiments, each medication card 1560 encloses a different medication such that each medication that is part of a patient's dosage regimen is organized on separate medication cards 1560. In some embodiments, medication card 1560 comprises receptacles 1572 indicating a patient's daily dosage of medication held within medication card 1560. In some embodiments, medication card 1560 comprises indicia, similar to indicia 1374, disposed with and displayed from a predetermined portion adjacent one or more receptacles 1572, indicating information regarding the medication enclosed within receptacles 1572.
In one embodiment, as shown in
In some embodiments, sleeve 1612 includes a panel 1622 disposed on at least one of top face 1614 and/or bottom face 1616. Panel 1622 is connected to sleeve 1612 along a side 1624 of panel 1622. Panel 1622 is configured to be opened and closed. In some embodiments, panel 1622 may include information, such as, for example, additional product literature, a place for the patient to take notes about their experiences with the medicines, and/or helpful tips. In some embodiments, panel 1622 is accessible without accessing scroll container 632.
Scroll container 1632 is configured for disposal within inner cavity 1620, similar to that as described herein. Scroll container 1632 is attached with sleeve 1612 by a tether 1633, similar to tether 1333, as described herein. Tether 1633 is configured such that scroll container 1632 is drawn from sleeve 1612 but not detachable from sleeve 1612. Tether 1633 is configured to provide a range of motion for movement of scroll container 1632 relative to sleeve 1612, similar to that as described herein.
In some embodiments, medicament dispensing system 10 is movable between a locked configuration and a non-locked configuration, similar to that described herein. In some embodiments, sleeve 1612 includes a closure panel, such as, for example, a flap 1650. Flap 1650 is configured for opening and closing sleeve 1612. In some embodiments, flap 1650 is configured for releasable engagement with sleeve 1612, such as, for example, by being folded about opening 1621 and tucked into sleeve 1612. In some embodiments, flap 1650 includes an opening, such as, for example, an arcuate slot 1652 configured to facilitate opening and closing of flap 1650 by allowing the user to grasp the surface of slot 1652 and draw and/or drag flap 1650 from sleeve 1612. Flap 1650 is configured to fold around scroll container 1632 and be inserted into sleeve 1612.
In some embodiments, sleeve 1612 is manufactured from a single piece of card stock, as shown in
It will be understood that various modifications may be made to the embodiments disclosed herein. Therefore, the above description should not be construed as limiting, but merely as exemplification of the various embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
This application claims the benefits of U.S. Provisional Patent Application No. 62/105,877 filed Jan. 21, 2015 and U.S. Provisional Patent Application No. 62/209,525 filed Aug. 25, 2015, the contents of each of these applications being hereby incorporated in their respective entireties by reference.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2016/014095 | 1/20/2016 | WO | 00 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2016/118605 | 7/28/2016 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 2415859 | Ancker | Feb 1947 | A |
| 2589735 | Salfisburg | Mar 1952 | A |
| 3054503 | Hartman, Jr. et al. | Sep 1962 | A |
| 3199489 | Ruoss et al. | Aug 1965 | A |
| 3279651 | Thompson | Oct 1966 | A |
| 3283885 | Grunewald et al. | Nov 1966 | A |
| 3305077 | Greif et al. | Feb 1967 | A |
| 3324996 | Jordt | Jun 1967 | A |
| 3367535 | Tanguay | Feb 1968 | A |
| 3387699 | Heller | Jun 1968 | A |
| 3472367 | Hellstrom | Oct 1969 | A |
| 3530818 | Secondino | Sep 1970 | A |
| 3567013 | Tannenbaum | Mar 1971 | A |
| 3579883 | Hayes | May 1971 | A |
| 3587517 | Fites et al. | Jun 1971 | A |
| 3630171 | Huck | Dec 1971 | A |
| 3630346 | Burnside | Dec 1971 | A |
| 3659706 | Serrell | May 1972 | A |
| 3722739 | Blumberg | Mar 1973 | A |
| 3809221 | Compere | May 1974 | A |
| 3835995 | Haines | Sep 1974 | A |
| 3856144 | Kelly | Dec 1974 | A |
| 3904075 | Richardson et al. | Sep 1975 | A |
| 3912081 | Haines et al. | Oct 1975 | A |
| 3921805 | Compere | Nov 1975 | A |
| 3924746 | Haines | Dec 1975 | A |
| 3924747 | Gerner | Dec 1975 | A |
| 4078660 | Lerro | Mar 1978 | A |
| RE29705 | Compere | Jul 1978 | E |
| 4158411 | Hall et al. | Jun 1979 | A |
| 4196809 | Tonrey | Apr 1980 | A |
| 4280621 | Tonrey | Jul 1981 | A |
| 4295567 | Knudsen | Oct 1981 | A |
| 4340141 | Fischer | Jul 1982 | A |
| 4384649 | Brodsky | May 1983 | A |
| 4429792 | Machbitz | Feb 1984 | A |
| 4483626 | Noble | Nov 1984 | A |
| 4526474 | Simon | Jul 1985 | A |
| 4534468 | Nuckols et al. | Aug 1985 | A |
| 4537312 | Intini | Aug 1985 | A |
| 4574954 | Reid | Mar 1986 | A |
| 4588090 | Spuck et al. | May 1986 | A |
| 4616316 | Hanpeter et al. | Oct 1986 | A |
| 4627432 | Newell et al. | Dec 1986 | A |
| 4662537 | Wolf et al. | May 1987 | A |
| 4664262 | White | May 1987 | A |
| 4736849 | Leonard et al. | Apr 1988 | A |
| 4817819 | Kelly | Apr 1989 | A |
| 4889236 | Bartell et al. | Dec 1989 | A |
| 4911327 | Shepherd et al. | Mar 1990 | A |
| 4955481 | Novinski et al. | Sep 1990 | A |
| 4974729 | Steinnagel | Dec 1990 | A |
| 4988004 | Intini | Jan 1991 | A |
| 5014851 | Wick | May 1991 | A |
| 5046618 | Wood | Sep 1991 | A |
| 5050739 | Hannan et al. | Sep 1991 | A |
| 5181189 | Hafner | Jan 1993 | A |
| 5236749 | Ewing | Aug 1993 | A |
| 5244091 | Tannenbaum | Sep 1993 | A |
| 5265728 | Allendorf et al. | Nov 1993 | A |
| 5310060 | Bitner et al. | May 1994 | A |
| 5323907 | Kalvelage | Jun 1994 | A |
| 5332096 | Battaglia | Jul 1994 | A |
| 5339960 | Price | Aug 1994 | A |
| 5358118 | Thompson et al. | Oct 1994 | A |
| 5360116 | Schmiletzky | Nov 1994 | A |
| 5405011 | Haber et al. | Apr 1995 | A |
| 5412372 | Parkhurst et al. | May 1995 | A |
| 5469968 | Matthews et al. | Nov 1995 | A |
| 5486390 | Burns et al. | Jan 1996 | A |
| 5489025 | Romick | Feb 1996 | A |
| 5511665 | Dressel et al. | Apr 1996 | A |
| 5522506 | Roulin et al. | Jun 1996 | A |
| 5549204 | Toren | Aug 1996 | A |
| 5560490 | Chawla | Oct 1996 | A |
| 5562232 | Pearson | Oct 1996 | A |
| 5613609 | Hamilton et al. | Mar 1997 | A |
| 5624036 | Roulin et al. | Apr 1997 | A |
| D384283 | Davies et al. | Sep 1997 | S |
| 5673793 | Seidler | Oct 1997 | A |
| 5695063 | Roulin et al. | Dec 1997 | A |
| 5758774 | Leblong | Jun 1998 | A |
| 5775505 | Vasquez et al. | Jul 1998 | A |
| 5794781 | Roulin et al. | Aug 1998 | A |
| D398521 | Coe | Sep 1998 | S |
| 5816404 | Seidler | Oct 1998 | A |
| 5819940 | Roulin et al. | Oct 1998 | A |
| 5878885 | Wangu et al. | Mar 1999 | A |
| 5878888 | Faughey et al. | Mar 1999 | A |
| 5904249 | Roulin et al. | May 1999 | A |
| 5911325 | Breitler | Jun 1999 | A |
| 5915558 | Girvetz | Jun 1999 | A |
| 5954204 | Grabowski | Sep 1999 | A |
| 5988429 | Coe | Nov 1999 | A |
| 6021392 | Lester et al. | Feb 2000 | A |
| 6024222 | Friberg et al. | Feb 2000 | A |
| 6036016 | Arnold | Mar 2000 | A |
| 6062420 | Krouwel et al. | May 2000 | A |
| 6082544 | Romick | Jul 2000 | A |
| 6098835 | Dejonge | Aug 2000 | A |
| 6155423 | Katzner et al. | Dec 2000 | A |
| 6155424 | Dubach | Dec 2000 | A |
| 6161699 | Gartland | Dec 2000 | A |
| 6219997 | Friberg et al. | Apr 2001 | B1 |
| 6253920 | Källgren | Jul 2001 | B1 |
| 6279736 | Hekal | Aug 2001 | B1 |
| 6301196 | Daniel | Oct 2001 | B1 |
| 6338408 | Anderson | Jan 2002 | B1 |
| 6349831 | Buss | Feb 2002 | B1 |
| 6352158 | Cole-Bennett et al. | Mar 2002 | B1 |
| 6364155 | Wolfe | Apr 2002 | B1 |
| 6375956 | Hermelin et al. | Apr 2002 | B1 |
| 6401926 | Lo | Jun 2002 | B1 |
| 6411567 | Niemiec et al. | Jun 2002 | B1 |
| 6412636 | Jones et al. | Jul 2002 | B1 |
| 6422391 | Swartz | Jul 2002 | B1 |
| 6460693 | Harrold | Oct 2002 | B1 |
| 6516949 | Fuller et al. | Feb 2003 | B2 |
| 6540081 | Balz et al. | Apr 2003 | B2 |
| 6574166 | Niemiec | Jun 2003 | B2 |
| 6601876 | Instance | Aug 2003 | B1 |
| 6641031 | Evans et al. | Nov 2003 | B2 |
| 6675972 | Patterson | Jan 2004 | B2 |
| 6708826 | Ginsberg et al. | Mar 2004 | B1 |
| 6752272 | Jones et al. | Jun 2004 | B2 |
| 6802422 | Kalvelage et al. | Oct 2004 | B2 |
| 6830153 | French et al. | Dec 2004 | B2 |
| 6832686 | Donegan | Dec 2004 | B2 |
| 6854618 | Harrold | Feb 2005 | B2 |
| 6874652 | Christensen et al. | Apr 2005 | B2 |
| 6896138 | Rock et al. | May 2005 | B2 |
| 6988618 | Dejonge | Jan 2006 | B2 |
| 7000768 | Morita et al. | Feb 2006 | B2 |
| 7000769 | Killinger et al. | Feb 2006 | B2 |
| 7051876 | Grosskopf | May 2006 | B2 |
| 7113101 | Petersen et al. | Sep 2006 | B2 |
| 7126879 | Snyder | Oct 2006 | B2 |
| 7150355 | Coe et al. | Dec 2006 | B2 |
| 7175044 | Benktzon et al. | Feb 2007 | B2 |
| 7188728 | Williams-Hartman | Mar 2007 | B2 |
| 7188729 | Dejonge | Mar 2007 | B2 |
| 7243797 | Donegan | Jul 2007 | B2 |
| 7243798 | Buss et al. | Jul 2007 | B2 |
| 7252208 | Alvino et al. | Aug 2007 | B1 |
| 7264137 | Drought et al. | Sep 2007 | B2 |
| 7284661 | Evans et al. | Oct 2007 | B1 |
| 7295890 | Jean-Pierre | Nov 2007 | B2 |
| 7325689 | Buss | Feb 2008 | B2 |
| 7331460 | Barndt et al. | Feb 2008 | B2 |
| 7336564 | Feodoroff | Feb 2008 | B2 |
| 7360652 | Arnold | Apr 2008 | B2 |
| 7377394 | Buss et al. | May 2008 | B2 |
| 7387206 | Grosskopf | Jun 2008 | B2 |
| 7395928 | Bertsch et al. | Jul 2008 | B2 |
| 7401702 | Hession | Jul 2008 | B2 |
| 7464819 | Maietta | Dec 2008 | B2 |
| 7481331 | Webster et al. | Jan 2009 | B2 |
| 7489594 | Simon et al. | Feb 2009 | B2 |
| 7494012 | Priebe et al. | Feb 2009 | B1 |
| 7497331 | Pham | Mar 2009 | B2 |
| 7542379 | Kimel et al. | Jun 2009 | B2 |
| 7552824 | Le et al. | Jun 2009 | B2 |
| 7584849 | Mauk et al. | Sep 2009 | B2 |
| 7588149 | Gelardi | Sep 2009 | B2 |
| D601337 | Hale | Oct 2009 | S |
| 7623040 | Cote | Nov 2009 | B1 |
| 7644822 | Elliott | Jan 2010 | B2 |
| 7658287 | Hession | Feb 2010 | B2 |
| 7699174 | Allison et al. | Apr 2010 | B2 |
| 7726485 | Brollier | Jun 2010 | B2 |
| 7748535 | Grosskopf | Jul 2010 | B2 |
| 7784250 | Grosskopf | Aug 2010 | B2 |
| 7802682 | Bitner | Sep 2010 | B2 |
| 7828149 | Kalvelage et al. | Nov 2010 | B2 |
| 7866476 | McGonagle et al. | Jan 2011 | B2 |
| 7926660 | Jones et al. | Apr 2011 | B2 |
| 7938265 | Bitner | May 2011 | B2 |
| 7967143 | Paliotta et al. | Jun 2011 | B2 |
| 7987985 | Ede et al. | Aug 2011 | B2 |
| 7997411 | Williams-Hartman | Aug 2011 | B2 |
| 8011512 | Brollier et al. | Sep 2011 | B2 |
| 8038008 | Bitner | Oct 2011 | B2 |
| 8079475 | McArthur et al. | Dec 2011 | B2 |
| 8085135 | Alloro et al. | Dec 2011 | B2 |
| 8091708 | Loftin et al. | Jan 2012 | B2 |
| 8091790 | Mickle et al. | Jan 2012 | B2 |
| 8154390 | Heath et al. | Apr 2012 | B2 |
| 8181772 | Short et al. | May 2012 | B2 |
| 8214077 | Bertrand et al. | Jul 2012 | B2 |
| 8220636 | Beecroft et al. | Jul 2012 | B2 |
| 8251219 | Lewis | Aug 2012 | B1 |
| 8312993 | Sams et al. | Nov 2012 | B2 |
| 8317026 | Hession et al. | Nov 2012 | B2 |
| 8333280 | Le | Dec 2012 | B2 |
| 8342331 | Ziemba et al. | Jan 2013 | B2 |
| 8392220 | Knowlton et al. | Mar 2013 | B2 |
| 8413813 | Grosskopf | Apr 2013 | B2 |
| 8443977 | Killinger et al. | May 2013 | B2 |
| 8444006 | Dixon | May 2013 | B2 |
| 8508346 | Heath et al. | Aug 2013 | B2 |
| 8544650 | Williams-Hartman | Oct 2013 | B2 |
| 8552868 | Ferguson | Oct 2013 | B1 |
| 8556077 | Hanley | Oct 2013 | B1 |
| 8567606 | Bellamah et al. | Oct 2013 | B2 |
| 8573403 | Stevens et al. | Nov 2013 | B2 |
| 8607982 | Jones | Dec 2013 | B2 |
| 8627957 | Ziemba et al. | Jan 2014 | B2 |
| 8672130 | Aldridge | Mar 2014 | B2 |
| 8679605 | Stevenson | Mar 2014 | B2 |
| 8689978 | Flood | Apr 2014 | B2 |
| 8701889 | Sams et al. | Apr 2014 | B2 |
| 9414993 | Flynn | Aug 2016 | B2 |
| 20010017273 | Raj et al. | Aug 2001 | A1 |
| 20020066690 | Mattis et al. | Jun 2002 | A1 |
| 20030024849 | Nielsen et al. | Feb 2003 | A1 |
| 20030111380 | Taneja et al. | Jun 2003 | A1 |
| 20030168376 | Taneja et al. | Sep 2003 | A1 |
| 20030209558 | Cross | Nov 2003 | A1 |
| 20040026293 | Hughes | Feb 2004 | A1 |
| 20040050746 | Dunlop et al. | Mar 2004 | A1 |
| 20040188312 | Stepowany | Sep 2004 | A1 |
| 20040188315 | Morita et al. | Sep 2004 | A1 |
| 20040256277 | Gedanke | Dec 2004 | A1 |
| 20050051454 | Coe et al. | Mar 2005 | A1 |
| 20050082194 | Fry et al. | Apr 2005 | A1 |
| 20050109658 | Bindford | May 2005 | A1 |
| 20050139506 | Lorenzato | Jun 2005 | A1 |
| 20050150897 | Fabricius et al. | Jul 2005 | A1 |
| 20050162979 | Ostergaard et al. | Jul 2005 | A1 |
| 20060042987 | Buss | Mar 2006 | A1 |
| 20060049078 | Sams et al. | Mar 2006 | A1 |
| 20060065670 | Doublet | Mar 2006 | A1 |
| 20060070895 | Khawaja | Apr 2006 | A1 |
| 20060086639 | Priebe et al. | Apr 2006 | A1 |
| 20060144749 | Arnold et al. | Jul 2006 | A1 |
| 20060157375 | Dejonge | Jul 2006 | A1 |
| 20070056876 | Jones | Mar 2007 | A1 |
| 20070068844 | Weston | Mar 2007 | A1 |
| 20070235366 | Desai et al. | Oct 2007 | A1 |
| 20070241552 | Watson et al. | Oct 2007 | A1 |
| 20070246395 | Arnold et al. | Oct 2007 | A1 |
| 20070267318 | Grosskopf | Nov 2007 | A1 |
| 20080017542 | Le et al. | Jan 2008 | A1 |
| 20080047969 | Farhan et al. | Feb 2008 | A1 |
| 20080078690 | Zumbiel | Apr 2008 | A1 |
| 20080202972 | Prud'Homme | Aug 2008 | A1 |
| 20080202973 | Prud'Homme | Aug 2008 | A1 |
| 20080230432 | Bobbett et al. | Sep 2008 | A1 |
| 20080302695 | Meeren et al. | Dec 2008 | A1 |
| 20090045096 | Knutson et al. | Feb 2009 | A1 |
| 20090065506 | Currie et al. | Mar 2009 | A1 |
| 20090084702 | Arnold et al. | Apr 2009 | A1 |
| 20090107873 | Cotton et al. | Apr 2009 | A1 |
| 20090109800 | Kimel et al. | Apr 2009 | A1 |
| 20090139893 | McGonagle et al. | Jun 2009 | A1 |
| 20090194434 | Ellis et al. | Aug 2009 | A1 |
| 20090288978 | Prud'Homme | Nov 2009 | A1 |
| 20100000899 | Burg et al. | Jan 2010 | A1 |
| 20100096292 | Jones | Apr 2010 | A1 |
| 20100102062 | Jones et al. | Apr 2010 | A1 |
| 20100126886 | Le | May 2010 | A1 |
| 20100181335 | Farrar et al. | Jul 2010 | A1 |
| 20100206765 | Fonte | Aug 2010 | A1 |
| 20100243507 | Gelardi et al. | Sep 2010 | A1 |
| 20110011756 | Bellamah | Jan 2011 | A1 |
| 20110108452 | Gelardi | May 2011 | A1 |
| 20110127320 | Sams et al. | Jun 2011 | A1 |
| 20110226765 | Gelardi | Sep 2011 | A1 |
| 20120024889 | Robertson et al. | Feb 2012 | A1 |
| 20120061276 | Gelardi et al. | Mar 2012 | A1 |
| 20120145586 | Doyle et al. | Jun 2012 | A1 |
| 20120160724 | Gelardi | Jun 2012 | A1 |
| 20120160726 | Gelardi | Jun 2012 | A1 |
| 20120267261 | Gelardi | Oct 2012 | A1 |
| 20130090937 | Wright | Apr 2013 | A1 |
| 20130112586 | Hawry et al. | May 2013 | A1 |
| 20130112588 | Flood et al. | May 2013 | A1 |
| 20130160408 | Neff | Jun 2013 | A1 |
| 20130161230 | Haering et al. | Jun 2013 | A1 |
| 20130285681 | Wilson et al. | Oct 2013 | A1 |
| 20130319902 | Tufi | Dec 2013 | A1 |
| 20140083900 | Ziemba et al. | Mar 2014 | A1 |
| 20140117060 | Colone et al. | May 2014 | A1 |
| 20140138430 | Loftin | May 2014 | A1 |
| 20140346184 | Bae | Nov 2014 | A1 |
| Entry |
|---|
| International Search Report and Written Opinion of the International Searching Authority dated May 2, 2016 and mailed Jun. 3, 2016 of International PCT Application No. PCT/US2016/014095 filed on Jan. 20, 2016. |
| Number | Date | Country | |
|---|---|---|---|
| 20180000691 A1 | Jan 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62105877 | Jan 2015 | US | |
| 62209525 | Aug 2015 | US |
